Oral and Nucleic Acid Vaccines for Zoonotic and Animal Infectious Diseases
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 578
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue will focus on the latest developments in oral and nucleic acid vaccines for the prevention and control of zoonotic and animal infectious diseases. It will encompass a range of topics, including vaccine design and process development, safety and efficacy evaluation, scale production and manufacturing process optimization, and the elucidation of the immunological mechanisms in various animal targets. The Issue aims to highlight the importance of these vaccines in reducing the infection and transmission of diseases between animals and humans, thereby improving public health and animal welfare. By featuring cutting-edge research, the Special Issue will provide a platform for scientists and health professionals to share knowledge and foster collaboration in the field of vaccine science.
Dr. Lei Shuai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oral vaccines
- nucleic acid vaccines
- zoonotic diseases
- animal infectious diseases
- vaccine development
- vaccine safety
- vaccine efficacy
- immunological mechanism
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
